Micafungin

Product NDC
42023-229
11-digit product format
420230229
Labeler code
42023
Product ID
42023-229_d1ed890c-2d2e-4e45-bb19-cd0929a17e0b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Micafungin
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Par Pharmaceutical, Inc.
Application
NDA212156
Marketing category
NDA
Marketing start
2021-08-01
Marketing end
0000-00-00
Substance
MICAFUNGIN SODIUM
Active strength
10 mg/mL
Pharmacologic classes
Echinocandin Antifungal [EPC], Lipopeptides [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct42023-229DDiscontinued by firm2026-10-05
excluded packagepackage42023-22942023-229-10DDiscontinued by firm2026-10-05

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N212156-001MICAFUNGINMICAFUNGIN SODIUMEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD2021-06-16
N212156-002MICAFUNGINMICAFUNGIN SODIUMEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD2021-06-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 70 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD2021-06-1684e616aacf4f…
2026-09-14 22:38:342026-08N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD2021-06-1684e616aacf4f…
2026-08-18 06:07:402026-07N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16caaa826d4ba7…
2026-08-18 06:07:402026-07N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16011fe1cb6892…
2026-02-19 14:30 UTC2026-02N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-1631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-1631067a03dcf5…
2025-08-23 18:47 UTC2025-08N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-166a471c1ec25d…
2025-08-23 18:47 UTC2025-08N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-166a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-1603ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-1603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-162680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-162680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-165bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-165bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16d06236e962d9…
2024-10-29 15:01 UTC2024-10N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-1679d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-1679d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-161e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-161e350fbaab3a…
2024-05-31 18:47 UTC2024-05N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-168072bd15b7f6…
2024-05-31 18:47 UTC2024-05N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-168072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-165c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-165c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-165d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-165d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-164b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-164b0b4de00fa7…
2022-03-09 01:35 UTC2022-03N212156-001MICAFUNGINEQ 50MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N212156-002MICAFUNGINEQ 100MG BASE/VIALPOWDER / INTRAVENOUSRLD, RS2021-06-16bb7c543d1eb4…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
04f262d4-f446-4cf7-b4fa-28b038cd7ee4Product name720260113
9c331f34-aa42-465c-8abd-4e929fba4e94Product name120250625

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
42023-229-10Micafungin10 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,1013
42023-229-10Micafungin10 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,1013

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
42023-229-10EA - Each42023-2297c3b9862-5669-49e9-bf00-874c60d4262412021-11-09

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
42023-229MICAFUNGIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ENDO USA, INC.]11Legacy NDC, 2 package rows20240915_70b3f044-95ca-4503-b669-ed39972592b6.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
861383micafungin sodium 100 MG InjectionPSN70b3f044-95ca-4503-b669-ed39972592b613
861379micafungin sodium 50 MG InjectionPSN70b3f044-95ca-4503-b669-ed39972592b613
861383micafungin 100 MG InjectionSCD70b3f044-95ca-4503-b669-ed39972592b613
861379micafungin 50 MG InjectionSCD70b3f044-95ca-4503-b669-ed39972592b613
861383micafungin 100 MG (equivalent to micafungin sodium 101.73 MG) InjectionSY70b3f044-95ca-4503-b669-ed39972592b613
861379micafungin 50 MG (equivalent to micafungin sodium 50.86 MG) InjectionSY70b3f044-95ca-4503-b669-ed39972592b613

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
42023-229-104202302291010 VIAL, SINGLE-DOSE in 1 CARTON (42023-229-10) > 10 mL in 1 VIAL, SINGLE-DOSE2021-08-010000-00-00NoNoCurrent